Wing Lam

发表

The Royal Flying Doctor Service of Australia: Devising a Database Strategy

Wing Lam, 2009 .

Novel Role of 3-Phosphoglycerate Kinase, a Glycolytic Enzyme, in the Activation of L-Nucleoside Analogs, a New Class of Anticancer and Antiviral Agents*

Elizabeth A. Gullen, Wing Lam, W. Lam, 2003, Journal of Biological Chemistry.

The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)

Edward Chu, Wing Lam, E. Chu, 2014, BMC Complementary and Alternative Medicine.

Simple and convenient G-quadruplex-based turn-on fluorescence assay for 3' → 5' exonuclease activity.

Dik-Lung Ma, Daniel Shiu-Hin Chan, Chung-Hang Leung, 2011, Analytical chemistry.

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment

Yingdong Zhao, Davide Bedognetti, Francesco M Marincola, 2011, BMC Medical Genomics.

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)

Wing Lam, W. Lam, Fulan Guan, 2018, Front. Pharmacol..

The Impact of Hypoxic Treatment on the Expression of Phosphoglycerate Kinase and the Cytotoxicity of Troxacitabine and Gemcitabine

Chung-Hang Leung, Wing Lam, C. Leung, 2007, Molecular Pharmacology.

Novel Mode of Action of Tylophorine Analogs as Antitumor Compounds

Wing Lam, W. Lam, Yung-Chi Cheng, 2004, Cancer Research.

Safety Surveillance of Traditional Chinese Medicine: Current and Future

Wing Lam, Yung-chi Cheng, W. Lam, 2015, Drug Safety.

Phosphorylation of Pyrimidine Deoxynucleoside Analog Diphosphates

Wing Lam, W. Lam, Yung-Chi Cheng, 2002, The Journal of Biological Chemistry.

Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).

Wei Zhang, Xin Li, Min Ye, 2010, Journal of chromatography. A.